NEW YORK (GenomeWeb News) – Life Technologies today said that it has established a partnership with researchers aimed at evaluating the use of its Ion Torrent PGM for influenza virus typing.

Life Tech said that it has formed the Global Influenza Network, a partnership with scientists at public health organizations, veterinary agencies, and research institutes that will focus on using the PGM to increase the spped and accuracy of influenza monitoring and vaccine development. The members will share tools, experience, and data using the semiconductor sequencing system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.